|
|
|
|
|
|
|
A , B, C, D, E ִµ, ߿ A B մϴ.
̱ A B ļ ǵǰ ֽϴ.
A μ()̸, ° ̴ κ ó ΰ ִ Դϴ. 츮 鵵 ȯ ӿ ± ü . |
|
̴ ° ȯ ӿ ɸ ɼ ū Ŀ A տ ϰ ˴ϴ.
Ǿ A ɸ ΰ ȴٴ Դϴ. A ǽϴ Դϴ. |
A ϱ 豺 |
|
A ϴ ϰų |
|
, ֻ ϴ |
|
ȯ ִ |
|
ڷ ϴ Ͽ ϴ |
|
ȯ |
|
ñ |
|
1 / 6-12 2 |
|
̻ |
|
̻ : ֻ , , , , °, Ŀ̻, ̻
年ϴ. |
|
|
|
|
|
|
|
|
|
|
A ñ |
|
|
Q1. A ¾ƾ ϳ? |
|
A ⺻ ƴ Դϴ.
A 70~80뿡 10 ̳ κ ü ִٰ ʾҴ Դϴ.
90뿡 鼭 ҾƵ ü Ÿ Ȯ ϴ ٴ ǰ 귯 ֽϴ.
̴ մϴ.
1ȸ 6~12 ̿ ߰ ϸ ˴ϴ. ͵ ֽϴ. |
|
Q2. A 2 Ѱ? |
|
μ ̱ 2 A ʽϴ.
FDA 2 ϴ ʾҽϴ.
ư A ϸ A ü ִ ü ؼ GMCs(geometric mean antibody comcentrations) ߸ ֽϴ. ٽ ϸ ȿ ִٴ Դϴ. ü ߾Ȼٴ ü ȿ ٴ پմϴ.
ֱٿ ǥ 5 Ϻ 18 A ص 鿪 ũ Ÿ ֽϴ.
θ A ü ü ϴ.
ϳ ̷ ο Ҽ θ A ü ο Ȯ ؼ µ ˴ϴ.
ֱ 鿡 ̷ κ ü Ծ [ A ü ] ε ص ٴ ɽ ֽϴ. ۿ ˷ ֽϴ.
A ü 2 ư A ص protective ü ˷ ֽϴ. 2 ص ɰ ۿ ϴ. |
|
|
|
|
|
|
|
|
|